Brusella endokarditi
Yıl: 2005 Cilt: 12 Sayı: 1 Sayfa Aralığı: 71 - 75 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
Brusella endokarditi
Öz: Brusella türü bakterilerin neden olduğu Brusella enfeksiyonu, insanlara hastalıklı hayvanlardan direkt veya pastörize edilmemiş süt ve süt ürünlerinin kullanımı ile indirekt olarak bulaşır. Türkiye'de Sağlık Bakanlığının 2001 yılında yayınladığı rapora göre 15 000 yeni olgu bildirilmiş, ancak rapor edilmeyen ve subklinik vakalar göz önüne alınırsa bu rakam her yıl 50-100 000 olarak düşünülebilir. Bu yüzden Brusella Türkiyede önemli bir sağlık problemidir. Brusella endokarditi Brusellozun nadir fakat hayatı tehdit eden bir komplikasyonu olmasına rağmen, son zamanlarda tıbbi ve cerrahi tedavi birlikteliğiyle mortalite oranı belirgin olarak düşmüştür. Brusella enfeksiyonunun %1'inden azında kardiak tutulum görülür. Bu sunumda brusella endokarditinin temel özellikleri özetlenmeye çalışılmıştır.
Anahtar Kelime: Konular:
Brucella endocarditis
Öz: Brucellosis is an infectious disease caused by the bacteria of the genus Brucella. Humans usually become infected by indirect contact with unpasteurized milk or dairy products or direct contact with infected animals. In Turkey, approximately 15.000 new cases of brucella are reported in year 2001 according to the data of the Ministry of Health. However it is believed that the real number of cases is at least 50.000-100.000 per year, when the unreported and subclinical cases are taken into account. Therefore, brucellosis still remains a serious health problem in Turkey. In clinical perspective, cardiac involvement with Brucella develops in less than 1% of cases. Although Brucella endocarditis is rare but a life-threatening complication of brucellosis, recently mortality rates have been reduced with used of combined medical and surgical treatment. In this review, we aimed to summarize the basic properties of Brucella endocarditis.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- Young JE: Brucella species. In: Principles and practice of infectious diseases Edited by: Mandell GL, Dolin R, Benett JE. Churchill Livingstone, New York; 1995:2053-57.
- Report of the WHO Working Group meeting on brucellosis control and research. Geneva, Switzerland, June 2-4, 1992. WHO/CDS/VPH/92:109.
- Karabay O, Sencan I, Kayas D, Şahin I. Ofloxacin plus Rifam- picin versus Doxycycline plus Rifampicin in the treatment of bru cellosis: a randomized clinical trial. BMC Infect Dis 2004, 4:18.
- Fernandez-Guerrero Ml. Zoonotic endocarditis. Inf Dis Clin N Am 1993; 7:135-52.
- Keleş C, Bozbuğa N, Şişmanoğlu M, et al. Surgical treatment of Brucella endocarditis. Ann Thorac Surg 2001; 71:1160-3.
- Al-Kasab S, Al-Fagih MR, Al-Yousef S, et al. Brucella infective endocarditis-successful combined medical and surgical therapy. J Thorac Cardiovasc Sur 1988; 95:862-7.
- Peery TM, Belter LF. Brucellosis and heart disease. Fatal brucellosis: a review of the literature and report of new cases. Am JPathol 1960; 36:673-95.
- Robichaud S, Libman M, Behr M, Rubin E. Prevention of laboratory-acquired brucellosis. Clin Infect Dis. 2004; 8:119-22.
- Shamelian SOA. Diagnosis and treatment of brucellosis. Neth JMed 2000; 56:198-9.
- Colmenero JD, Reguera JM, Martos F, et al.Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine 1996; 75:195-211.
- Chomel BB, DeBess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973-1992 and shift toward foodborne transmission. J Infect Dis 1994; 170:1216-23.
- Young EJ. Human brucellosis. Rev Infect Dis 1983;5:821-842.
- Fernandez-Guerrero, ML, Martinell, J, Aguado JM, Ponte MC, Fraile J, de Rabago G. Prosthetic valve endocarditis caused by Brucella melitensis. A report of four cases successfully treated with tetracycline, streptomycin, and sulfamethoxazole and trimethoprim plus valve replacement. Arch Intern Med 1987; 147:1141-3.
- Lubani M, Sharda D, Helin I. Cardiac manifestations in brucellosis. Arch Dis Child 1986; 61:569-72.
- Al-Kasab SA, Al-Fagih M, Rasheed A, et al. Management of brucella endocarditis with aortic root abscess. Chest 1990;9 8:1532-4.
- Delvecchio G, Fracassetti O, Lorenzi N. Brucella endocarditis. Int J Cardiol 1991; 33:328-9.
- Jacobs F, Abramowicz D, Vereersraeten P, Le Clerc JL, Zech F, Thys JP. Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis 1990; 12:740-4.
- Jeroudi MO, Halim MA, Harder EJ, Al-Sibai MB, Ziady G, Mercer EN. Brucella endocarditis. Br Heart J 1987; 58:279-83.
- Aygen B, Doğanay M, Sümerkan B, Yildiz O, Kayabaş Ü. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med maladies infect 2002; 32:485-93.
- Valiatu J, Shuhaiber H, Kiwan Y, Araj G, Chough T. Brucella endocarditis and review of the literature. J Cardiovasc Surg 1989;30:782-5.
- Martin Moreno S, Guinea Esquerdo L, Carrero Gonzalez P, et al. Diagnosis of brucellosis in an endemic area. Evaluation of routine diagnostic tests. Med Clin (Bare). 1992; 98:481-5.
- Gotuzzo E, Carrillo C. Brucella .In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases, 2nd Ed., W.B. Saunders Co., 1998:1837-44.
- Leandro J, Roberto H, Antunes M. Brucella endocarditis of the aortic valve. Eur J Cardio-thorac. 1998; 13:95-7.
- Gotuzzo E, Carrîllo C, Guerra J, Llosa L. An evaluation of diagnostic methods for brucellosis-the value of bone marrow culture. J Infect Dis. 1986; 153:122-5.
- Ozturk R, Mert A, Koçak F, Ozaras R, Koksal F, Tabak F, Bilir M, Aktuglu Y.The diagnosis of brucellosis by use of BACTEC 9240 blood culture system. Diagn Microbiol Infect Dis. 2002; 44:133-5.
- Navas E, Guerrero A, Cobo J, Loza E. Faster isolation of Brucella spp. from blood by isolator compared with BACTEC NR. Diagn Micr Infec Dis. 1993; 16:79-81.
- Görgülü Ş, Çelik S, Tezel T. İnfektif endokarditli hastanın yönlendirilmesinde ekokardiyografik bulguların yeri. Türk Kardiyol Dem Arş. 2003; 31:42-9.
- Irani WN, Grayburn PA, Afridi I. A negative transthoracic echocardiogram obviates the need for transesophageal echocardiography in patients with suspected native valve active infective endocarditis. Am J Cardiol. 1996; 78:101-3.
- Roe MT, Abrramson MA, Li J, et al. Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the Duke criteria. Am Heart J. 2000; 139:945-51.
- Choussat R, Thomas D, Isnard R, et al. Perivalvuler abscesses associated with endocarditis: clinical features and prognostic factors of overall survival in a series of 233 cases. Eur Heart J. 1999; 20:232-41.
- Daniel WG, Mugge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by Transe sophageal echocardiography. N Engl J Med. 1991; 324:795-800.
- Reguera JM, Alarcon A, Miralles F, Pachon J, Juarez C, Colmenero JD. Brucella endocarditis: clinical, diagnostic, and therapeutic approach. Eur J Clin Microbiol. 2003; 22:647-50.
- Flugelman MY, Galun E, Ben-Chetrit E, Caraco J, Rubinow A. Brucellosis in patients with heart disease: when should endocarditis be diagnosed? Cardiology. 1990; 77:313-7.
- Micozzi A, Venditti M, Gentile G, Alessandri N, Santera M, Martino P. Succesful treatment of brucella melitensis endocarditis with pefloxacin. Eur J Clin Microbiol. 1990; 9:440-2.
- Cohen N, Golik A, Alon I, et al. Conservative treatment for brucella endocarditis. Clin Cardiol. 1997; 20:291-4.
- Hadjinikolau L, Triposkiadis F, Zairis M, Chlapoutakis E, Spyrou P. Succesful management of brucella melitensis endocarditis with combined medical and surgical approach. Eur J Cardio-thorac. 2001; 19:806-10.
- Doganay M, Aygen B: Use of Ciprofloxacin in treatment of bru cellosis. Eur Journal of Clin Microbiol & Infect Dis. 1992; 11:74-5.
- Food and Agricultural Organization-World Health Organization. FAO-WHO Expert Committee on Brucellosis, 6th report. WHO Tech. Rep. Ser. 1986; 740: 56-7.
- Ariza J, Gudiol F, Pallares R, Femandez-Viladrich P, Rufi G, Correddoira J, Miravitiles M. Treatment of human brucellosis with doxycycline plus rifampicin or doxycycline plus streptomycin. Annals of Internal Medicine. 1992; 117:25-30.
- Solera J, Martinez AE, Espinosa A. Recognition and optimum treatment of brucellosis. Drugs. 1997; 53:245-56.
- Duran E, Sunar H, Ege T, Canbaz S. Excision of aortic vegetation in Brucella endocarditis. Asian Cardiovasc Thorac Ann. 2001; 9:59-61.
| APA | ÖZKÖKELİ M, KARABAY O, ARINÇ H, TATAROĞLU C (2005). Brusella endokarditi. , 71 - 75. |
| Chicago | ÖZKÖKELİ Mehmet,KARABAY OĞUZ,ARINÇ Hüseyin,TATAROĞLU Cenk Brusella endokarditi. (2005): 71 - 75. |
| MLA | ÖZKÖKELİ Mehmet,KARABAY OĞUZ,ARINÇ Hüseyin,TATAROĞLU Cenk Brusella endokarditi. , 2005, ss.71 - 75. |
| AMA | ÖZKÖKELİ M,KARABAY O,ARINÇ H,TATAROĞLU C Brusella endokarditi. . 2005; 71 - 75. |
| Vancouver | ÖZKÖKELİ M,KARABAY O,ARINÇ H,TATAROĞLU C Brusella endokarditi. . 2005; 71 - 75. |
| IEEE | ÖZKÖKELİ M,KARABAY O,ARINÇ H,TATAROĞLU C "Brusella endokarditi." , ss.71 - 75, 2005. |
| ISNAD | ÖZKÖKELİ, Mehmet vd. "Brusella endokarditi". (2005), 71-75. |
| APA | ÖZKÖKELİ M, KARABAY O, ARINÇ H, TATAROĞLU C (2005). Brusella endokarditi. MN Kardiyoloji, 12(1), 71 - 75. |
| Chicago | ÖZKÖKELİ Mehmet,KARABAY OĞUZ,ARINÇ Hüseyin,TATAROĞLU Cenk Brusella endokarditi. MN Kardiyoloji 12, no.1 (2005): 71 - 75. |
| MLA | ÖZKÖKELİ Mehmet,KARABAY OĞUZ,ARINÇ Hüseyin,TATAROĞLU Cenk Brusella endokarditi. MN Kardiyoloji, vol.12, no.1, 2005, ss.71 - 75. |
| AMA | ÖZKÖKELİ M,KARABAY O,ARINÇ H,TATAROĞLU C Brusella endokarditi. MN Kardiyoloji. 2005; 12(1): 71 - 75. |
| Vancouver | ÖZKÖKELİ M,KARABAY O,ARINÇ H,TATAROĞLU C Brusella endokarditi. MN Kardiyoloji. 2005; 12(1): 71 - 75. |
| IEEE | ÖZKÖKELİ M,KARABAY O,ARINÇ H,TATAROĞLU C "Brusella endokarditi." MN Kardiyoloji, 12, ss.71 - 75, 2005. |
| ISNAD | ÖZKÖKELİ, Mehmet vd. "Brusella endokarditi". MN Kardiyoloji 12/1 (2005), 71-75. |
